Mafham M, Zayed M, Collins R, Sabatine M, et al. HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics. Am Heart J 2026 Aug 7:107546. doi: 10.1016/j.ahj.2026.107546.
PMID: 42567431